Evidence map›Paper›PMID 34085165›Full record

ArticleCell biochemistry and biophysics2021

Nuclear Sphingosine-1-phosphate Lyase Generated ∆2-hexadecenal is A Regulator of HDAC Activity and Chromatin Remodeling in Lung Epithelial Cells.

David L Ebenezer, Ramaswamy Ramchandran, Panfeng Fu, Lizar A Mangio, Vidyani Suryadevara, Alison W Ha, Evgeny Berdyshev, Paul P Van Veldhoven, Stephen J Kron, Fabian Schumacher and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cell biochemistry and biophysics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. A role for plasma membrane CaPflugers Archiv : European journal of physiology · 2024
    Article
  4. Review
  5. Epigenetic Regulation Mediated by Sphingolipids in Cancer.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

David L EbenezerDepartments of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Ramaswamy RamchandranDepartments of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Panfeng FuThe Affiliated Hospital of School of Medicine, Ningbo University, Ningbo, China.
Lizar A MangioDepartments of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Vidyani SuryadevaraDepartments of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Alison W HaDepartment of Biochemistry & Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.
Evgeny BerdyshevDepartment of Medicine, National Jewish Medical Center, Denver, CO, USA.
Paul P Van VeldhovenLIPIT, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Stephen J KronDepartment of Molecular Genetics and Cell Biology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, USA.
Fabian SchumacherInstitute of Pharmacy, Department of Pharmacology & Toxicology, Freie Universität Berlin, Berlin, Germany.
Burkhard KleuserInstitute of Pharmacy, Department of Pharmacology & Toxicology, Freie Universität Berlin, Berlin, Germany.
Viswanathan NatarajanDepartments of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL, USA. visnatar@uic.edu.ORCID http://orcid.org/0000-0002-5132-8212
University of Illinois Chicago · USFreie Universität Berlin · DEKU Leuven · BENational Jewish Health · USNingbo University Affiliated Hospital · CNUniversity of Chicago · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI Joe G. N. Garcia · 2016 to 2026
$24.4M
Role of Sphingolipid Pathways in the Pathobiology of PAHR01HL127342 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MACHADO, ROBERTO F., NATARAJAN, VISWANATHAN · 2016 to 2023
$4.5M
Lipid signaling in cellular senescence and tissue agingR01AG069865 · NIA · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2020 to 2024
$1.8M
Foundation for the National Institutes of Health HLBI P01HL126609, P01HL060678, R01HL127342NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R01 HL127342NIA NIH HHS R01 AG069865
6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P), a bioactive lipid mediator, is generated from sphingosine by sphingosine kinases (SPHKs) 1 and 2 and is metabolized to ∆2-hexadecenal (∆2-HDE) and ethanolamine phosphate by S1P lyase (S1PL) in mammalian cells. We have recently demonstrated the activation of nuclear SPHK2 and the generation of S1P in the nucleus of lung epithelial cells exposed to Pseudomonas aeruginosa. Here, we have investigated the nuclear localization of S1PL and the role of ∆2-HDE generated from S1P in the nucleus as a modulator of histone deacetylase (HDAC) activity and histone acetylation. Electron micrographs of the nuclear fractions isolated from MLE-12 cells showed nuclei free of ER contamination, and S1PL activity was detected in nuclear fractions isolated from primary lung bronchial epithelial cells and alveolar epithelial MLE-12 cells. Pseudomonas aeruginosa-mediated nuclear ∆2-HDE generation, and H3/H4 histone acetylation was attenuated by S1PL inhibitors in MLE-12 cells and human bronchial epithelial cells. In vitro, the addition of exogenous ∆2-HDE (100-10,000 nM) to lung epithelial cell nuclear preparations inhibited HDAC1/2 activity, and increased acetylation of Histone H3 and H4, whereas similar concentrations of S1P did not show a significant change. In addition, incubation of ∆2-HDE with rHDAC1 generated five different amino acid adducts as detected by LC-MS/MS; the predominant adduct being ∆2-HDE with lysine residues of HDAC1. Together, these data show an important role for the nuclear S1PL-derived ∆2-HDE in the modification of HDAC activity, histone acetylation, and chromatin remodeling in lung epithelial cells.

Indexed as

Aldehyde-LyasesAldehydesCell NucleusChromatin Assembly and DisassemblyEpithelial CellsHistonesLungPseudomonas aeruginosaAcetylationAnimalsCell LineFemaleHistone Deacetylase 1Histone Deacetylase 2Histone DeacetylasesHumans2-hexadecenalAldehyde-LyasesAldehydesHistone Deacetylase 1Histone Deacetylase 2Histone DeacetylasesHistonesLysophospholipidsSGPL1 protein, humanSgpl1 protein, mouseSphingosinesphingosine 1-phosphatesphingosine 1-phosphate lyase (aldolase)HDAC1/2HexadecenalHistone acetylationNuclear S1PPseudomonas-induced lung inflammationS1P lyase

Identifiers

PMID34085165
PMCPMC9128239
OpenAlexW3165124063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.